NCT03134937

Brief Summary

High Flow Heated and Humidified Nasal Oxygen therapy (HFHHNO) has been increasingly used in emergency medicine to assist patients with short term respiratory failure and to provide adequate oxygen to the body prior to intubation. Gastric distension which is the bloating of the stomach due to air being pumped into it is a concern for anesthesiologists as it increases the risk of nausea and vomiting during surgery (aspiration). The objective of this study is use an ultrasound machine to measure the volume of fluid in the stomach before and after HFNO is used in a standard clinical manner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 1, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

November 6, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2019

Completed
Last Updated

September 10, 2019

Status Verified

February 1, 2019

Enrollment Period

1.4 years

First QC Date

February 16, 2017

Last Update Submit

September 6, 2019

Conditions

Keywords

Gastric UltrasoundGastric DistensionGastric VolumeGastric Fluid VolumeHigh-flow oxygen therapyHFHHNOHealthy volunteer

Outcome Measures

Primary Outcomes (1)

  • Change in Gastric Volume

    Ultrasound scan will be used to determine if there was an increase in gastric fluid volume following session of oxygen therapy.

    Prior to, and immediately following session of HFHHNO oxygen therapy.

Secondary Outcomes (1)

  • Gastric Distension

    Immediately following session of HFHHNO oxygen therapy.

Study Arms (1)

Study Arm

OTHER

Participants will undergo one session of high-flow heated and humidified oxygen therapy (HFHHNO) (up to 60-70 litre/min). They will undergo a gastric ultrasound scan after session of HFHHNO therapy.

Device: High-Flow Heated and Humidified Oxygen Therapy (HFHHNO)

Interventions

Participants will undergo one session of high-flow heated and humidified oxygen therapy (HFHHNO) (up to 60-70 litre/min). They will undergo a gastric ultrasound scan after session of HFHHNO therapy.

Study Arm

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers aged 18 to 70 years
  • Male or female
  • American Society of Anesthesia physical status classification I and II
  • Height greater than 145 cm
  • Ability to understand the study protocol and provide informed consent. Communication difficulties will not be an impediment to participate. In case of a language barrier, translation services will be sought as per usual institutional practice.

You may not qualify if:

  • Subjects predisposed to have an increased residual gastric volume at baseline (e.g. diabetes or known gastric dysmotility)
  • History of major upper gastrointestinal disease (including hiatus hernia or prior gastroduodenal surgery)
  • Morbid obesity (Body Mass Index \> 40 Kg/m2)
  • Chronic Obstructive Pulmonary Disease (Emphysema or Chronic Bronchitis)
  • Subjects diagnosed with type I and II Diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

Location

Related Publications (1)

  • McLellan E, Lam K, Behringer E, Chan V, Bozak D, Mitsakakis N, Perlas A. High-flow nasal oxygen does not increase the volume of gastric secretions during spontaneous ventilation. Br J Anaesth. 2020 Jul;125(1):e75-e80. doi: 10.1016/j.bja.2020.02.023. Epub 2020 Mar 31.

Study Officials

  • Anahi Perlas, MD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Every participant will recieve one HFHHNO session, will get 30 mins of oxygen up to 60-70 L/min.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2017

First Posted

May 1, 2017

Study Start

November 6, 2017

Primary Completion

March 20, 2019

Study Completion

March 20, 2019

Last Updated

September 10, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

No IPD is to be shared with other researchers. All data will be obtained during an gastric ultrasound scan.

Locations